Contrast ultrasound assessment of angiogenesis by perfusion and molecular imaging.

Abstract:

:There is great interest in the development of noninvasive methods for imaging angiogenic responses. Strategies for assessing angiogenesis have primarily relied on measuring perfusion-related characteristics, such as total blood flow or microvascular volume, or detecting abnormal vascular permeability. Techniques are now being developed that are capable of imaging the cellular and molecular alterations associated with neovessel growth and development. Contrast-enhanced ultrasound is a noninvasive imaging method that has great promise in terms of its ability to characterize changes in either microvascular perfusion or vascular endothelial phenotype. Techniques for evaluating perfusion by contrast ultrasound rely on the measurement of both microvascular blood volume and velocity. Accordingly, this technique can provide unique information on abnormalities in microvascular density and perfusion associated with adaptive and pathologic angiogenesis. Contrast ultrasound methods for imaging vascular phenotype during angiogenesis have also been developed by surface conjugation of ligands against endothelial cell markers of vascular development such as alpha(v)-integrins and growth factor receptors. Due to the high resolution of the technique and the rapid imaging protocols, there is great enthusiasm for the continued development and testing of these techniques. For perfusion imaging, translation to the clinical setting is already taking place, whereas molecular imaging faces many more hurdles in terms of safety and testing efficacy.

journal_name

Expert Rev Mol Diagn

authors

Heppner P,Lindner JR

doi

10.1586/14737159.5.3.447

keywords:

subject

Has Abstract

pub_date

2005-05-01 00:00:00

pages

447-55

issue

3

eissn

1473-7159

issn

1744-8352

journal_volume

5

pub_type

杂志文章,评审
  • Clinical implications of and lessons learnt from external assessment of Mers-CoV diagnostics.

    abstract::With the emergence of new viral infections, it is necessary to set up new target-specific assays, based on existing molecular techniques such as real-time PCR, as quickly as possible. Without these diagnostic tools, the geographical spread of new infections, follow-up of the disease outbreak and analysis of the pathog...

    journal_title:Expert review of molecular diagnostics

    pub_type: 社论

    doi:10.1586/14737159.2016.1116943

    authors: Pas SD,Koopmans MP,Niedrig M

    更新日期:2016-01-01 00:00:00

  • Investigating lubricin and known cartilage-based biomarkers of osteoarthritis.

    abstract::Introduction: Osteoarthritis (OA) is a degenerative disease which primarily affects hyaline cartilage, leading to pain, stiffness and loss of mobility of the entire articulation. Diagnosis is commonly based on symptoms and radiographs, but there is a growing interest in detecting novel biomarkers, in serum, urine and ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:10.1080/14737159.2020.1733978

    authors: Ravalli S,Szychlinska MA,Lauretta G,Di Rosa M,Musumeci G

    更新日期:2020-04-01 00:00:00

  • Molecular diagnostics for hereditary hearing loss in children.

    abstract:INTRODUCTION:Hearing loss (HL) is the most common birth defect in industrialized countries with far-reaching social, psychological and cognitive implications. It is an extremely heterogeneous disease, complicating molecular testing. The introduction of next-generation sequencing (NGS) has resulted in great progress in ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2017.1340834

    authors: Sommen M,Wuyts W,Van Camp G

    更新日期:2017-08-01 00:00:00

  • MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury.

    abstract:INTRODUCTION:Drug-induced liver injury (DILI) is a severe adverse drug reaction which is of major concern to patients, clinicians and the pharmaceutical industry. Accurate and rapid detection of DILI is important for patient stratification and treatment in the clinic and benefits preclinical drug design and risk assess...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2018.1415145

    authors: Howell LS,Ireland L,Park BK,Goldring CE

    更新日期:2018-01-01 00:00:00

  • Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.

    abstract::Lipoprotein-associated phospholipase (Lp-PL)A2 is a recently described and potentially useful plasma biomarker associated with cardiovascular disease. The enzyme, originally named platelet-activating factor acetylhydrolase (PAF-AH), has two prominent biological activities. First, it inactivates the prominent proinflam...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.7.5.511

    authors: Carlquist JF,Muhlestein JB,Anderson JL

    更新日期:2007-09-01 00:00:00

  • The role of molecular diagnostic testing in the management of thyroid nodules.

    abstract:INTRODUCTION:Fine needle aspiration (FNA) with cytologic examination remains the standard of care for investigation of thyroid nodules. However, as many as 30% of FNA samples are cytologically indeterminate for malignancy, which confounds clinical management. To reduce the burden of repeat diagnostic testing and unnece...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2017.1321987

    authors: Moore MD,Panjwani S,Gray KD,Finnerty BM,Zarnegar R,Fahey TJ 3rd

    更新日期:2017-06-01 00:00:00

  • High-resolution DNA melting analysis in clinical research and diagnostics.

    abstract::Among nucleic acid analytical methods, high-resolution melting analysis is gaining more and more attention. High-resolution melting provides simple, homogeneous solutions for variant scanning and genotyping, addressing the needs of today's overburdened laboratories with rapid turnaround times and minimal cost. The fle...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.09.84

    authors: Montgomery JL,Sanford LN,Wittwer CT

    更新日期:2010-03-01 00:00:00

  • The promise of methylation on beads for cancer detection and treatment.

    abstract::Despite numerous technical hurdles, the realization of true personalized medicine is becoming a progressive reality for the future of patient care. With the development of new techniques and tools to measure the genetic signature of tumors, biomarkers are increasingly being used to detect occult tumors, determine the ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2014.943665

    authors: Guzzetta AA,Pisanic Ii TR,Sharma P,Yi JM,Stark A,Wang TH,Ahuja N

    更新日期:2014-09-01 00:00:00

  • Oligonucleotide microarrays in constitutional genetic diagnosis.

    abstract::Oligonucleotide microarrays such as comparative genomic hybridization arrays and SNP microarrays enable the identification of genomic imbalances - also termed copy-number variants - with increasing resolution. This article will focus on the most significant applications of high-throughput oligonucleotide microarrays, ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.11.32

    authors: Keren B,Le Caignec C

    更新日期:2011-06-01 00:00:00

  • Next-generation sequencing in precision oncology: challenges and opportunities.

    abstract::High throughput gene sequencing is transforming the utilization of genomics in patient care by providing physicians with a powerful tool to aid the diagnosis and management of disease, particularly in precision oncology. As next-generation sequencing (NGS)-based diagnostic assays are developed, significant hurdles suc...

    journal_title:Expert review of molecular diagnostics

    pub_type: 社论

    doi:10.1586/14737159.2014.916213

    authors: Kruglyak KM,Lin E,Ong FS

    更新日期:2014-07-01 00:00:00

  • Emerging techniques in molecular detection of circulating tumor cells.

    abstract::Circulating tumor cells (CTCs) are increasingly recognized for their potential utility in cancer diagnosis and prognosis. Emerging technologies in the past decade have allowed possible isolation and characterization of CTCs in the peripheral blood of cancer patients, including immunomagnetic technique coupled with imm...

    journal_title:Expert review of molecular diagnostics

    pub_type: 社论

    doi:10.1586/14737159.2014.868308

    authors: Cho WC

    更新日期:2014-03-01 00:00:00

  • Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.

    abstract::The Introduction of targeted therapeutics into clinical practice has created major opportunities for further development of the molecular diagnostics industry. Emerging genomic and proteomic technologies and information are now resulting in the molecular subclassification of disease as the basis for diagnosis, prognos...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2.6.531

    authors: Ross JS,Ginsburg GS

    更新日期:2002-11-01 00:00:00

  • Label-free mass spectrometry-based proteomics for biomarker discovery and validation.

    abstract::For most diseases, better biomarkers are urgently needed to enable (early) detection, diagnosis, prognosis, stratification for therapy and response monitoring. Proteomics delineates gene products that carry out the majority of cellular functions, and thereby may not only yield insight into altered signaling pathways i...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.12.31

    authors: Pham TV,Piersma SR,Oudgenoeg G,Jimenez CR

    更新日期:2012-05-01 00:00:00

  • Progress in circulating tumor cell capture and analysis: implications for cancer management.

    abstract::The hematogenous dissemination of cancer and development of distant metastases is the cause of nearly all cancer deaths. Detection of circulating tumor cells (CTCs) as a surrogate biomarker of metastases has gained increasing interest. There is accumulating evidence on development of novel technologies for CTC detecti...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.12.12

    authors: Balic M,Lin H,Williams A,Datar RH,Cote RJ

    更新日期:2012-04-01 00:00:00

  • TRAC in high-content gene expression analysis: applications in microbial population studies, process biotechnology and biomedical research.

    abstract::More than a decade of intensive use of microarray technology has flooded the scientific community with genome-wide expression data of diverse biological states. As a result, connection of the expression signatures of a relatively small number of genes related to, for example, disease states, patient responses or toxic...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.8.4.379

    authors: Rautio JJ,Satokari R,Vehmaan-Kreula P,Serkkola E,Söderlund H

    更新日期:2008-07-01 00:00:00

  • Prognostic and predictive biomarkers in melanoma: an update.

    abstract::Malignant melanoma is one of the most aggressive cancers. Several new therapeutic strategies that focus on immuno- and/or targeted therapy have been developed, which have entered clinical trials or already been approved. This review provides an update on prognostic and predictive biomarkers in melanoma that may be use...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2016.1126511

    authors: Foth M,Wouters J,de Chaumont C,Dynoodt P,Gallagher WM

    更新日期:2016-01-01 00:00:00

  • A history of microarrays in biomedicine.

    abstract::The fundamental strategy of the current postgenomic era or the era of functional genomics is to expand the scale of biologic research from studying single genes or proteins to studying all genes or proteins simultaneously using a systematic approach. As recently developed methods for obtaining genome-wide mRNA express...

    journal_title:Expert review of molecular diagnostics

    pub_type: 历史文章,杂志文章

    doi:10.1586/14737159.5.3.315

    authors: Ewis AA,Zhelev Z,Bakalova R,Fukuoka S,Shinohara Y,Ishikawa M,Baba Y

    更新日期:2005-05-01 00:00:00

  • Prognostic and predictive biomarkers in prostate cancer.

    abstract::Prostate cancer (PCa) is one of the leading causes of cancer death among males, especially in more developed countries. Diagnosis is often achieved at an early stage of the disease with prostate biopsy, following a screening test showing elevated serum levels of prostate-specific antigen or a positive digital rectal e...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2015.1110022

    authors: Kontos CK,Adamopoulos PG,Scorilas A

    更新日期:2015-01-01 00:00:00

  • A review of novel technologies and techniques associated with identification of bloodstream infection etiologies and rapid antimicrobial genotypic and quantitative phenotypic determination.

    abstract:INTRODUCTION:The antimicrobial aspect of management of patients with blood stream infections (BSI) and sepsis is time critical. In an era of increasing antimicrobial resistance, rapid detection and identification of bacteria with antimicrobial susceptibility is crucial to direct therapy early in the course of illness. ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2018.1480369

    authors: Poole S,Kidd SP,Saeed K

    更新日期:2018-06-01 00:00:00

  • Lung cancer screening: utility of molecular applications in conjunction with low-dose computed tomography guidelines.

    abstract::Finding early-stage lung cancer where there is a higher chance for patient survival remains a major healthcare challenge. Low-dose spiral computed tomography for high-risk patients can increase the detection of cancers with certain tradeoffs, such as increased radiation exposure and surgical risks for false-positive c...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2016.1149469

    authors: Palma JF,Das P,Liesenfeld O

    更新日期:2016-01-01 00:00:00

  • Advantages and limitations of nanoparticle labeling for early diagnosis of infection.

    abstract:INTRODUCTION:Nanoparticle-based disease diagnostics harness a range of unique physical and chemical phenomena for the detection of biomarkers at exceedingly low levels. This capability potentially enables the diagnosis of disease earlier in its progression and improves the likelihood of positive treatment outcomes. Thi...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1080/14737159.2016.1205489

    authors: Laurentius LB,Owens NA,Park J,Crawford AC,Porter MD

    更新日期:2016-08-01 00:00:00

  • Genomic and proteomic approaches for Chagas' disease: critical analysis of diagnostic methods.

    abstract::Trypanosoma cruzi is the etiologic agent of Chagas' disease, a chronic inflammatory condition that results in heart and digestive complications. The first draft of the parasite genome is now complete and it is expected that, along with the published genomic and proteomic analyses discussed herein, it will lead to the ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.5.4.521

    authors: Huete-Pérez JA,Flores-Obando RE,Ghedin E,Caffrey CR

    更新日期:2005-07-01 00:00:00

  • Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer.

    abstract::Noninvasive tests for detecting genetic or molecular alterations in urine indicative of urothelial cancer are increasingly becoming the focus of urological cancer research. Since its approval by the US FDA in 2001, the fluorescence in situ hybridization test (Vysis UroVysion) has been widely evaluated. In general, pub...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.7.1.11

    authors: Arentsen HC,de la Rosette JJ,de Reijke TM,Langbein S

    更新日期:2007-01-01 00:00:00

  • Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.

    abstract::Indeterminate thyroid lesions are diagnosed in up to 30% of fine needle aspirations. These nodules harbor malignancy in more than 25% of cases, and hemithyroidectomy or total thyroidectomy has therefore been advocated in order to achieve definitive diagnosis. Recently, many molecular markers have been investigated in ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.2013.811893

    authors: Keutgen XM,Filicori F,Fahey TJ 3rd

    更新日期:2013-07-01 00:00:00

  • Near instrument-free, simple molecular device for rapid detection of herpes simplex viruses.

    abstract::The first near instrument-free, inexpensive and simple molecular diagnostic device (IsoAmp HSV, BioHelix Corp., MA, USA) recently received US FDA clearance for use in the detection of herpes simplex viruses (HSV) in genital and oral lesion specimens. The IsoAmp HSV assay uses isothermal helicase-dependent amplificatio...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.12.34

    authors: Lemieux B,Li Y,Kong H,Tang YW

    更新日期:2012-06-01 00:00:00

  • Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease.

    abstract::Alzheimer's disease is the most common form of dementia in the elderly and its prevalence is rapidly rising. Although there is no cure for Alzheimer's disease, treatment can be administered to slow progression or delay the onset of symptoms. A major challenge is the early identification of patients who will develop Al...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.4.1.63

    authors: Chang CY,Silverman DH

    更新日期:2004-01-01 00:00:00

  • Epigenetic alteration of microRNAs in feces of colorectal cancer and its clinical significance.

    abstract::MicroRNAs regulate target gene expression through translation repression or mRNA decay, and they are emerging as important modulators in cellular pathways. Previous studies have shown the occurrence of epigenetically modified miRNAs in colorectal cancer (CRC), identifying these miRNA methylation signatures may provide...

    journal_title:Expert review of molecular diagnostics

    pub_type: 评论,杂志文章

    doi:10.1586/erm.11.57

    authors: Cho WC

    更新日期:2011-09-01 00:00:00

  • Advances in quantitative immunohistochemistry and their contribution to breast cancer.

    abstract::Introduction: Automated image analysis provides an objective, quantitative, and reproducible method of measurement of biomarkers. Image quantification is particularly well suited for the analysis of tissue microarrays which has played a major pivotal role in the rapid assessment of molecular biomarkers. Data acquired ...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章

    doi:10.1080/14737159.2020.1743178

    authors: Yaghoobi V,Martinez-Morilla S,Liu Y,Charette L,Rimm DL,Harigopal M

    更新日期:2020-05-01 00:00:00

  • Geographic ancestry and markers of preterm birth.

    abstract::Several biomarkers associated with spontaneous preterm birth (PTB) have been discovered over the last decade. Many of these markers, such as cytokines, are associated with infection and inflammation. As such, these biomarkers represent biologically plausible candidates for assessing those at risk of PTB. However, in t...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/erm.09.70

    authors: Williams SM,Velez DR,Menon R

    更新日期:2010-01-01 00:00:00

  • Bioinformatic approaches for modeling the substrate specificity of HIV-1 protease: an overview.

    abstract::HIV-1 protease has a broad and complex substrate specificity, which hitherto has escaped a simple comprehensive definition. This, and the relatively high mutation rate of the retroviral protease, makes it challenging to design effective protease inhibitors. Several attempts have been made during the last two decades t...

    journal_title:Expert review of molecular diagnostics

    pub_type: 杂志文章,评审

    doi:10.1586/14737159.7.4.435

    authors: Rögnvaldsson T,You L,Garwicz D

    更新日期:2007-07-01 00:00:00